Abstract 993
Background
Curative resection improves the outcome of the patients with local recurrence of rectal cancer (LRRC). On the other hand, the role of perioperative radiotherapy for LRRC still remains controversial.
Methods
To assess surgical treatment and perioperative radiotherapy for the patients with LRRC, 49 patients (male-female ratio, 29:20) who underwent the surgical treatment for LRRC in a single institution since 1990, were clinicopathologically analyzed.
Results
27 patients (55%) had radiotherapy (preoperative (pre): 15, postoperative (post): 12). The median dose of radiation was 60 Gy (28-72). Perioperative radiotherapy tended to be carried out for the patients with LRRC, which tumor location was close to pelvic wall. Total pelvic exenteration, abdominoperineal resection, tumor excisions, Hartmann’s operation, and low anterior resection were performed in 8, 21, 12, 6 and 2 patients, respectively. Out of 49 patients, 36 patients (73%) had curative resection (R0) and 13 patients (27%) had non-curative resection (R1, R2). R0 rate was higher in the patients without radiotherapy (86%) compared to the patients with radiotherapy (pre and post: 67% and 58%, respectively). Overall complications were observed in 39 patients (80%) after surgery for LRRC. The rate of intrapelvic abscess was doubled in the patients with preoperative radiotherapy compared to the patients without radiotherapy. The median operative time, blood loss, and hospital stay after surgery were 530 min, 1966 ml, and 40 days, respectively. The hospital stay after surgery was significantly longer in the patients with preoperative radiotherapy than the patients without radiotherapy (39 vs 66 days, p = 0.018). Three-years survival rate of all 49 patients and 36 patients with R0 resection were 56% and 64%, respectively. No three-years survivors were observed in the patients with noncurative resections (R2).
Conclusions
Curative resection improves the prognosis of the patients with LRRC. Preoperative radiotherapy may increase the complications, resulting in prolongation of patient’s hospital stay.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
Hideaki Karasawa.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
890 - Prognostic Nomogram Based on Lymph Node Ratio to Predict Survival in Node-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Presenter: Jianguo Lai
Session: Poster display - Cocktail
Resources:
Abstract
307 - Breast tumor associated exosomes mediate loss of antitumor immune response by arresting cytotoxic T cell functions in the tumor microenvironment
Presenter: Soumya Chatterjee
Session: Poster display - Cocktail
Resources:
Abstract
734 - Hormonal therapy confers clinically relevant benefit in women with low estrogen receptor-positive breast tumor
Presenter: Tianjiao Zhang
Session: Poster display - Cocktail
Resources:
Abstract
187 - Breast board comined with a thermoplastic head mask immobilization can improve the reproducibility of the treatment setup for breast cancer patients who received whole breast and supraclavicular nodal region irradiation
Presenter: Ming wei Ma
Session: Poster display - Cocktail
Resources:
Abstract
189 - Imaging-proven Venous Thromboembolism Breast Cancer in a Tertiary Hospital in the Philippines
Presenter: Amabelle Trina Gerona
Session: Poster display - Cocktail
Resources:
Abstract
746 - Tumor-infiltrating lymphocytes and pathologic complete response among the patients with HER2 positive breast cancer receiving neoadjuvant docetaxel, carboplatin, trastuzumab and pertuzumab (TCHP) : Single center experience
Presenter: Jooyoung Ha
Session: Poster display - Cocktail
Resources:
Abstract
786 - PD-L1 expression on circulating monocytes in patients with breast cancer
Presenter: Mayuko Nagano
Session: Poster display - Cocktail
Resources:
Abstract
1089 - Dosimetric plan evaluation of hypofractionated 3-Dimensional Conformal Radiotherapy (3DCRT) and 2-Dimensional (2D) simulator planning in whole breast irradiation after breast conserving surgery
Presenter: Mukul Roy
Session: Poster display - Cocktail
Resources:
Abstract
1344 - IQGAP3 Overexpression Correlates with Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
Presenter: huanxin Lin
Session: Poster display - Cocktail
Resources:
Abstract
190 - A reliable nomogram for predicting overall survival in patients with triple-negative breast cancer
Presenter: Ming Wei Ma
Session: Poster display - Cocktail
Resources:
Abstract